Majority stake in HumanOptics AG to be sold to Chinese investor
Ad-hoc-Mitteilung gemäß Art. 17 MAR
Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.
End of the Ad-hoc-Disclosure
Spardorfer Str. 150
Telefon: +49 (0) 9131 50665-0